Celtic Lux Holdings, formerly Alvogen Lux Holdings, purchased 10,133,333 shares of Alvotech at $3.75 per share on June 16, 2026. This transaction was reported to the Luxembourg financial regulator, CSSF, indicating significant insider activity. The purchase reflects confidence in Alvotech, a global biotech company specializing in biosimilars. This move follows Alvotech's recent successful public offering raising $165 million, signaling potential growth and investor interest.
FTI Consulting appointed Jerome Nyssen as Senior Managing Director in its Risk Advisory practice in Australia to enhance AI-driven risk, compliance, and governance services. Nyssen brings 25 years of experience across financial services and technolog...
General Fusion has made significant progress with its LM26 Magnetized Target Fusion machine, achieving plasma electron temperatures of about 8.4 million degrees Celsius (0.72 keV), nearing its 1 keV target. This milestone demonstrates effective plasm...
AI/R, a technology company specializing in Agentic AI, has deepened its partnership with Databricks, achieving Gold partner status and expanding its certifications from 11 to over 100. This growth enables AI/R to deliver advanced AI and data solution...
Kudu Investment Management has acquired a minority stake in Drummond Capital Partners, an Australian boutique investment manager specializing in managed accounts. Drummond's founders will retain majority ownership and continue operating under the sam...
Cohen & Steers Board of Directors declared monthly dividend distributions for July, August, and September 2026 for several closed-end funds. Dividends range from $0.080 to $0.165 per share depending on the fund. Some funds follow managed distribution...
